Every month, MedicinMan in partnership with IMS Health, brings our readers the latest industry numbers related to sales and revenues of different companies, brands and therapy areas in the Indian Pharmaceutical Market.
The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,426 crores in the month of August 2016 clocking a strong 18% growth over same period last year (SPLY). This was the second consecutive month where the IPM crossed the 10,000 crore mark.
The Indian Pharmaceutical Market (IPM) was valued atRs. 10,025 crores in the month of July 2016 clocking a 14.7% growth over same period last year (SPLY). This was the first time ever the market crossed the 10,000 crore mark in a single month.
The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,278 crs in the month of September 2016 clocking a strong 10% growth over same period last year (SPLY). On a MAT September basis, the industry was valued at Rs. 111,022 crores and reflected a 13% growth with volumes contributing around 40% of this growth and New Introductions playing an important role with around 38% contribution to the overall growth.
Articles by K. Hariram, Pankaj Mehrotra, Rinkesh Shah, Gopal Kishore, Amaninder S. Dhillon, Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, and Mahendra Kumar Rai
How long before digital Unicorns like Ola, Swiggy, Pharmeasy, and many others realize the humongous opportunity of delivering health care at the doorstep?
Imagine an app like Ola, where instead of entering where you want to go, you enter the nature of your medical need/emergency and search and find a range of hospitals/doctors/paramedics who can act as the first responders and reach your home in an ambulance or a motorbike with an HCP as a pillion rider with all necessary equipment from the thermometer to defibrillator depending on the nature of the medical care needed and triage and route you/your loved ones to the nearest hospital with an indicative cost of treatment in partnership with health insurance companies?
HomeField Force Excellence conference+CEO Roundtable
Field Force Excellence conference+CEO Roundtable
[metaslider id=2309]
Field Force Excellence (FFE)+CEO Roundtable is MedicinMan’s flagship Field Force Excellence conference bringing together industry thought leaders and senior managers to set the annual agenda for Field Force Excellence in the industry.
Past topics include:
Practical Issues in Sales Force Effectiveness (SFE) implementation
Role Clarity from Front-line Manager to National Sales Manager
Role of Technology as a Field Force Multiplier
Social Learning for the Field Force
Data Analytics: Actionable Insights for Segmented Marketing
Role of Marketing, Medical, HR and L&D in Building the Rx Capabilities of the Field Force
Navigating UCPMP, MCI Guidelines and other regulatory issues
Reinvention of Doctor-Field Force interaction through Digital and Social
Business Intelligence for Field Force Productivity
Employee Engagement: The New Paradigm for Enhancing Field Force Productivity
Past CEO Roundtable participants include:
K. Hariram – Managing Director, (retd.), Galderma India
Sanjiv Navangul – Managing Director, Janssen India
K. Shivkumar – Managing Director, Eisai Pharmaceuticals
